1857 Federal Register / Vol. 89, No. 8 / Thursday, January 11, 2024 / Proposed Rules 
1. Ethylene dichloride (CAS No. 107– 
06–2); 
2. Methylene chloride (CAS No. 75– 
09–2); and 
3. Trichloroethylene (CAS No. 79–01– 
6). 
II. Request To Amend 21 CFR Part 73 
In accordance with the procedure in 
section 721(d) of the FD&C Act for 
issuance, amendment, or repeal of regulations, the petition asks us to amend §§ 73.1, 73.30, 73.345, and 73.615 to remove ethylene dichloride, methylene chloride, and trichloroethylene. Specifically, the petitioners state these substances have been found to induce cancer in humans or animals and, therefore, are not safe pursuant to section 721(b)(5)(B) of the FD&C Act (also referred to as the ‘‘Delaney Clause’’). The Delaney Clause provides, in relevant part, that no color additive shall be deemed safe for any use which will or may result in ingestion of all or part of such additive, if the additive is found by the Secretary of Health and Human Services (Secretary) to induce cancer when ingested by man or animal, or if it is found by the Secretary, after tests which are appropriate for the evaluation of the safety of additives for use in food, to induce cancer in man or animal. 
The petition is available in the docket. 
We invite comments, additional scientific data, and other information related to the issues raised by this petition. If we determine that the available data justify amending §§ 73.1, 73.30, 73.345, and 73.615 to remove ethylene dichloride, methylene chloride, and trichloroethylene, we will publish our decision in the Federal Register in accordance with 21 CFR 
71.20. 
The petitioners have claimed that this 
action is categorically excluded under 21 CFR 25.32(m), which applies to an action to prohibit or otherwise restrict or reduce the use of a substance in food, food packaging, or cosmetics. In addition, the petitioners have stated that, to their knowledge, no extraordinary circumstances exist (see 21 CFR 25.21). If FDA determines a categorical exclusion applies, neither an environmental assessment nor an environmental impact statement is required. If FDA determines a categorical exclusion does not apply, we will request an environmental assessment and make it available for public inspection. Dated: January 8, 2024. 
Lauren K. Roth, 
Associate Commissioner for Policy. 
[FR Doc. 2024–00410 Filed 1–10–24; 8:45 am] 
BILLING CODE 4164–01–P 
DEPARTMENT OF HEALTH AND 
HUMAN SERVICES 
Food and Drug Administration 
21 CFR Parts 172 and 173 
[Docket No. FDA–2023–F–5684] 
Filing of Food Additive Petition From 
Environmental Defense Fund, et al.; Request To Amend the Food Additive Regulations To Remove the Solvents Benzene, Ethylene Dichloride, Methylene Chloride, and 
Trichloroethylene 
AGENCY : Food and Drug Administration, 
HHS. 
ACTION : Notification of petition. 
SUMMARY : The Food and Drug 
Administration (FDA or we) is announcing that we have filed a food additive petition, submitted by Environmental Defense Fund, et al., proposing that the food additive regulations be amended to remove four specified solvents. 
DATES : The food additive petition was 
filed on December 21, 2023. Submit either electronic or written comments on the filing notice by March 11, 2024. 
ADDRESSES : You may submit comments 
as follows. Please note that late, untimely filed comments will not be considered. The https://www.regulations.gov electronic filing 
system will accept comments until 11:59 p.m. Eastern Time at the end of March 11, 2024. Comments received by mail/hand delivery/courier (for written/ paper submissions) will be considered timely if they are received on or before that date. 
Electronic Submissions 
Submit electronic comments in the 
following way: 
•Federal eRulemaking Portal: 
https://www.regulations.gov. Follow the 
instructions for submitting comments. 
Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to 
the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such 
as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. 
•If you want to submit a comment 
with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). 
Written/Paper Submissions 
Submit written/paper submissions as 
follows: 
•Mail/Hand Delivery/Courier (for 
written/paper submissions): Dockets 
Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. 
•For written/paper comments 
submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for 
information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ 
Instructions: All submissions received 
must include the Docket No. FDA– 2023–F–5684 for ‘‘Filing of Food Additive Petition from Environmental Defense Fund, et al.; Request To Amend the Food Additive Regulations To Remove the Solvents Benzene, Ethylene Dichloride, Methylene Chloride, and Trichloroethylene.’’ Received comments, those filed in a timely manner (see DATES), will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the 
Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240–402–7500. 
•Confidential Submissions—To 
submit a comment with confidential information that you do not wish to be made publicly available, submit your comment only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ We will review this copy, including the claimed confidential information, in our consideration of comments. The second copy, which will have the claimed confidential information redacted/ blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both 
copies to the Dockets Management Staff. If you do not wish your name and 
VerDate Sep<11>2014 17:01 Jan 10, 2024 Jkt 262001 PO 00000 Frm 00011 Fmt 4702 Sfmt 4702 E:\FR\FM\11JAP1.SGM 11JAP1ddrumheller on DSK120RN23PROD with PROPOSALS11858 Federal Register / Vol. 89, No. 8 / Thursday, January 11, 2024 / Proposed Rules 
contact information to be made publicly 
available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ‘‘confidential.’’ Any information marked as ‘‘confidential’’ will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA’s posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.govinfo.gov/content/pkg/FR-2015- 09-18/pdf/2015-23389.pdf. 
Docket: For access to the docket to 
read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the 
docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240–402–7500. 
FOR FURTHER INFORMATION CONTACT : 
Paulette M. Gaynor, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240–402–1192. 
SUPPLEMENTARY INFORMATION : 
I. Background 
Under section 409(b)(5) of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 348(b)(5)), we are giving notice that we have filed a food additive petition (FAP 4A4839), submitted by Environmental Defense Fund, Breast Cancer Prevention Partners, Center for Environmental Health, Environmental Working Group, and Lisa Lefferts, c/o Lisa Lefferts, Nellysford, VA 22958. The petition proposes that we amend §§ 172.560 (21 CFR 172.560, ‘‘Modified hop extract’’), 172.710 (21 CFR 172.710, ‘‘Adjuvants for pesticide use dilutions’’), 173.230 (21 CFR 173.230, ‘‘Ethylene dichloride’’), 173.255 (21 CFR 172.255, 
‘‘Methylene chloride’’), 173.290 (21 CFR 173.290, ‘‘Trichloroethylene’’), and 173.315 (21 CFR 173.315, ‘‘Chemicals used in washing or to assist in the peeling of fruits and vegetables’’) to remove the use of four specified solvents. 
The four solvents that are the subject 
of this petition are: 
1. Benzene (CAS No. 71–43–2); 
2. Ethylene dichloride (CAS No. 107–06– 
2); 
3. Methylene chloride (CAS No. 75–09–2); 
and 
4. Trichloroethylene (CAS No. 79–01–6). II. Request To Amend 21 CFR Parts 172 
and 173 
In accordance with the procedures for 
amending or repealing a food additive regulation in § 171.130 (21 CFR 171.130), the petition asks us to amend §§ 172.560, 172.710, 173.230, 173.255, 173.290, and 173.315 to remove benzene, ethylene dichloride, methylene chloride, and trichloroethylene. Specifically, the petitioners state that these substances have been found to induce cancer in humans or animals and, therefore, are not safe pursuant to section 409(c)(3)(A) of the FD&C Act (also referred to as the ‘‘Delaney Clause’’). The Delaney Clause provides that no food additive shall be deemed to be safe if it is found to induce cancer when ingested by man or animal, or if it is found after tests which are appropriate for the evaluation of the safety of food additives, to induce cancer in man or animal. 
The petition is available in the docket. 
We invite comments, additional scientific data, and other information related to the issues raised by this petition. If we determine that the available data justify amending §§ 172.560, 172.710, 173.230, 173.255, 173.290, and 173.315 to remove benzene, ethylene dichloride, methylene chloride, and trichloroethylene, we will publish our decision in the Federal Register in accordance with § 171.130. 
The petitioners have claimed that this 
action is categorically excluded under 21 CFR 25.32(m), which applies to an action to prohibit or otherwise restrict or reduce the use of a substance in food, food packaging, or cosmetics. In addition, the petitioners have stated that, to their knowledge, no extraordinary circumstances exist (see 21 CFR 25.21). If FDA determines a categorical exclusion applies, neither an environmental assessment nor an environmental impact statement is required. If FDA determines a categorical exclusion does not apply, we will request an environmental assessment and make it available for public inspection. 
Dated: January 8, 2024. 
Lauren K. Roth, 
Associate Commissioner for Policy. 
[FR Doc. 2024–00411 Filed 1–10–24; 8:45 am] 
BILLING CODE 4164–01–P DEPARTMENT OF THE TREASURY 
Internal Revenue Service 
26 CFR Part 1 and 301 
[REG–118492–23; REG–113064–23; REG– 
120080–22] 
RIN 1545–BQ99; RIN 1545–BQ86; RIN 1545– 
BQ52 
Section 30D Excluded Entities; 
Transfer of Clean Vehicle Credits Under Section 25E and Section 30D; Section 30D New Clean Vehicle Credit; Hearing 
AGENCY : Internal Revenue Service (IRS), 
Treasury. 
ACTION : Notice of proposed rulemaking; 
notice of hearing. 
SUMMARY : This document provides a 
notice of public hearing on proposed regulations that would provide guidance regarding the proposed regulations under sections 25E, 30D, and 6213 with respect to the clean vehicle credits as amended by the Inflation Reduction Act of 2022. 
DATES : The public hearing on these 
proposed regulations has been scheduled for Wednesday, January 31, 2024, at 10 a.m. ET. The IRS must receive speakers’ outlines of the topics to be discussed at the public hearing by Thursday, January 18, 2024. If no outlines are received by Thursday, January 18, 2024, the public hearing will be cancelled. 
ADDRESSES : The public hearing is being 
held in the Auditorium, at the Internal Revenue Service Building, 1111 Constitution Avenue NW, Washington, DC. Due to security procedures, visitors must enter at the Constitution Avenue entrance. In addition, all visitors must present a valid photo identification to enter the building. Because of access restrictions, visitors will not be admitted beyond the immediate entrance area more than 30 minutes before the hearing starts. Participants may alternatively attend the public hearing by telephone. 
Send Submissions to CC:PA:01:PR 
(REG–130080–22, REG–113064–23, and REG–118492–23), Room 5205, Internal Revenue Service, P.O. Box 7604, Ben Franklin Station, Washington, DC 20044. Submissions may be hand delivered Monday through Friday to CC:PA:01:PR (REG–130080–22, REG– 113064–23, and REG–118492–23), Couriers Desk, Internal Revenue Service, 1111 Constitution Avenue NW, Room 5205, Washington, DC 20224 or sent electronically via the Federal eRulemaking Portal at 
VerDate Sep<11>2014 17:01 Jan 10, 2024 Jkt 262001 PO 00000 Frm 00012 Fmt 4702 Sfmt 4702 E:\FR\FM\11JAP1.SGM 11JAP1ddrumheller on DSK120RN23PROD with PROPOSALS1